Sonveaux P, Labar D, Van Hée V, Dehon G, Frédérick R. [18F]-labelled lactate derivative as PET radiotracer . Priority date: 09 September 2016. Filling number: EP16188093.
Sonveaux P, Payen VL, Vazeille T, Porporato P, Niebes P. Composition antimétastatique comprenant au moins un compose de type flavonol. [Antimetastatic composition comprising at least a flavonol-related compound]. Priority date: 10 November 2014. Filing number: Filling number: PCT/EP2015/076248. BE100000468. US 5,523,983
Draoui N, Feron O, Riant O, Sonveaux P, Schicke O, Fernandes A, Kilonda A, Vanherck JC, Marchand A. 3-carboxy substituted coumarin derivatives with a potential utility for the treatment of cancer diseases. Filed July 2013. Filling number: PCT/EP2014/061921. Publication number: WO2014195507A1.
Dewhirst MW, Stamler JS, McMahon TJ, Sonveaux P. Use of an agent that restores tissue perfusion and oxygenation. US 7,338,670 B2. Priority date: 14 April 2005. Filling number: 60/671,179. Granted date: 04 March 2008. Publication numbers: US 7,338,670 B2, US 7,790,204 B2, WO2006113540.
Dewhirst MW, Sonveaux P, Feron O, Schroeder T, Wahl ML. Use of agents that inhibit cancer growth by simultaneously targeting tumor cell metabolism and angiogenesis. Priority date: 05 February 2007. Filling number: US provisional patent application n°2796.
Li CY, Li F, Sonveaux P, Dewhirst MW. Inhibition of HIF-1 activation for anti-tumor and anti-inflammatory responses. Priority date: 30 March 2006. Filling number: 60/787,373. Publication number: US 2007/0297984 A1.
Sonveaux P, Dessy C, Feron O. Use of endothelin-1 antagonists for improving cancer therapy. Priority date: 15 May 2003. Filling number: 60/470,679. Publication number: WO2004100991A1.